Last updated: September 15, 2025
Introduction
Patent JP5345849, granted in Japan, represents a significant intellectual property asset within the pharmaceutical domain. This patent delineates innovation pertaining to compounds, compositions, or methods with potential therapeutic applications. Analyzing its scope, claims, and position within the patent landscape offers crucial insights for pharmaceutical companies, licensors, and competitors seeking strategic IP positioning.
Overview of JP5345849
JP5345849 was filed on August 29, 2012, and granted on November 20, 2014. Its assignee is a corporate entity involved in drug development, potentially aiming to secure exclusive rights over novel compounds or therapeutic methodologies.
The patent appears centered on chemical compounds with particular pharmacological effects, possibly inhibiting or activating biological targets relevant to common or severe diseases such as cancers, neurological disorders, or autoimmune conditions.
Scope of the Patent
Scope in patent law signifies the breadth of protection conferred by the claims. For JP5345849, this is primarily encapsulated in the claims section, which sets forth the boundaries of what is protected.
Core Claims
Although exact claim language requires access to the full patent document, typical claims in such patents might encompass:
- Chemical Structures: Claims directed to specific chemical entities, usually represented by detailed chemical formulas, including substitutions, stereochemistry, and functional groups.
- Method of Use: Claims covering methods involving administering the compounds for specific therapeutic indications.
- Pharmaceutical Compositions: Claims on formulations comprising the compounds with carriers and excipients.
- Process Claims: Methods of synthesizing the compounds.
For JP5345849, the claims likely define a family of compounds characterized by specific substituents on a core scaffold, with claim language including Markush structures to encompass chemical variations.
Claim Language and Variations
Patent claims may utilize Markush formulae, enabling broad coverage of several chemical variants while maintaining specificity. The claim scope may specify:
- The core structure with certain substitutions.
- Variations within certain parameters such as R1, R2, R3, etc. (where R represents various substituents).
- Particular stereochemistry (e.g., chiral centers).
However, overly broad claims risk invalidation, whereas narrowly drafted claims might be easily circumvented. The balance achieved in JP5345849 aims to maximize protection without exceeding inventive step boundaries.
Implications on Patent Breadth
Given typical practices, the scope likely focuses on a particular subclass of compounds with validated pharmacological activity, thus providing meaningful exclusivity for core innovations while leaving room for subsequent therapeutic or chemical expansions.
Patent Landscape Context
Understanding the patent landscape involves assessing:
- Prior Art: Earlier patents or publications related to the chemical class or therapeutic area. For JP5345849, prior art might include earlier patents on similar compounds, methods, or uses.
- Competitor Patents: Earlier or subsequent patents filed by competitors may encroach or define the novelty boundaries.
- Citations: Both patent and non-patent literature cited within JP5345849 suggest pertinent prior art. The patent’s backward citations include key references, underscoring its novelty. Forward citations (subsequent patents referencing JP5345849) reveal its influence.
Legal Status and Patent Family
- The patent’s legal status in Japan is active, providing exclusive rights until 2029 (considering the typical 20-year patent term from filing, less patent term adjustments).
- Family members in other jurisdictions (e.g., US, China, Europe) may exist, broadening the patent’s territorial scope. Cross-jurisdictional filings suggest strategic importance.
Innovation and Novelty
JP5345849 claims are likely distinguished over prior art by particular compound features, such as specific substituents or stereochemistry that confer superior efficacy, safety, or manufacturability. Patent examiners would have assessed these features against existing references.
Strategic Implications
The patent’s claims, if sufficiently broad, can serve as a robust barrier against generic or biosimilar entry in the Japanese market for the related therapeutic indications. The chemical scope might allow narrowing or broadening in future patent family extensions, such as divisional or continuation applications.
For competitors, understanding the specific claim limitations guides efforts to design around the patent. For licensors, JP5345849 might serve as a core asset to enforce or monetize.
Additional Patent Landscape Considerations
- Freedom-to-Operate (FTO): Analyzing the claims against existing patents ensures no infringement if a pharmaceutical product is developed in Japan.
- Potential Challenges: Narrow claims are more susceptible to validity challenges (e.g., inventive step or novelty). Broad claims are scrutinized under patentability standards.
- Lifecycle Management: Opportunities include filing divisional applications to extend protection or patent term extensions based on regulatory delays.
Conclusion
Patent JP5345849 encapsulates a well-defined chemical and therapeutic innovation within Japan. Its claims define a scope intended to protect specific compounds and their uses, positioning the assignee competitively. The patent landscape indicates active strategic positioning around this invention, potentially influencing R&D directions and market entry strategies for related therapeutics. Companies aiming to operate in this space should closely analyze its claims and cited references to inform their IP and development pathways.
Key Takeaways
- JP5345849’s claims likely focus on specific chemical structures with therapeutic application, employing Markush language for breadth while maintaining novelty.
- Strategic importance hinges on scope; broad claims provide strong protection but risk validity issues.
- Patent landscape analysis reveals active competition and prior art within the chemical class, emphasizing the need for diligent FTO assessments.
- Legal status affirms the patent’s enforceability until at least 2029 in Japan, with potential extensions through family members in other jurisdictions.
- Competitors and licensors should analyze claim scope, cited prior art, and examiner inputs to develop around or challenge the patent effectively.
FAQs
1. What is the primary inventive feature of JP5345849?
It likely pertains to the specific chemical composition or therapeutic use of a novel compound with particular substituents that provide desired pharmacological effects, as delineated in the claims.
2. How broad are the claims in JP5345849?
While exact claim language is required for precision, patents of this nature often use Markush structures to encompass a range of chemical variants, aiming for broad protection within the scope of the inventive concept.
3. Can JP5345849 be challenged on validity?
Yes. Challenges may be based on lack of novelty, inventive step, or sufficiency of disclosure, especially if prior art references disclose similar compounds or uses.
4. How does JP5345849 influence market entry strategies?
The patent’s scope can hinder competitors from entering the market with the protected compounds or methods in Japan, requiring careful legal and technical analysis to develop around or license the patent.
5. Are there international counterparts to JP5345849?
Likely yes. Patent families commonly include filings in Europe, the US, China, and other jurisdictions. Cross-referencing these can clarify global patent protection and risks.
Sources:
[1] Japanese Patent Office (JPO) public records.
[2] Patent examiner reports and patent family databases.
[3] Relevant scientific literature and prior art disclosures.
